Status:
COMPLETED
Intermittent Fasting in Adults With Type 1 Diabetes
Lead Sponsor:
University of Illinois at Chicago
Conditions:
Type 1 Diabetes
Obesity
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The majority of adults with type 1 diabetes (T1DM) have either overweight or obesity. As such, dietary management has been recommended as an adjunct to insulin treatment to improve glycemic control an...
Eligibility Criteria
Inclusion
- Age between 18 to 75 years old
- BMI between 25 and 50 kg/m2
- Previously diagnosed with T1DM and currently using insulin
- HbA1c: 6.5-9.5% (regardless of medication use)
- On either multiple daily doses of insulin (MDI) program or using an insulin pump (with or without closed loop feature) 11
- Active prescription for glucagon
Exclusion
- Previously diagnosed with T2DM
- Have a history of eating disorders (anorexia, bulimia, or binge eating disorder)
- Are not weight stable for 3 months prior to the beginning of study (weight gain or loss \> 4 kg)
- Are not able to keep a food diary for 7 consecutive days during screening
- Are eating less than a 10-hour window at baseline
- Are pregnant, or trying to become pregnant
- Are night shift workers
- History of severe hypoglycemia defined as requiring help from others, needed to use emergency glucagon administration in the past 6 months.
- Other significant medical history including heart failure, unstable coronary artery disease, chronic obstructive pulmonary disease requiring oxygen, cirrhosis, active cancer, history of stroke, end stage renal disease
Key Trial Info
Start Date :
November 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06134986
Start Date
November 20 2023
End Date
September 1 2025
Last Update
November 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois Chicago
Chicago, Illinois, United States, 60612